CABTREO 1.2%-0.15%-3.15% GEL

clindamycin phosphate/benzoyl peroxide/adapalene
$18.2075per GM

Strength

1.5; 31; 12 mg/g; mg/g; mg/g

NDC

00187000625

Classification

Brand

Dosage Form

GEL

Route

TOPICAL

Last Updated

9/17/2025

Approval Type

New Drug (NDA)

FDA Application

NDA216632

On Market Since

10/20/2023

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade
Retinoid
Retinoids

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.2%

3Y

N/A

5Y

N/A

All

+0.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.